CEO SUMMARY: Faced with a literal tidal wave of new medical procedures, new therapeutic drugs, and new diagnostic tests, Medicare is crafting a unique strategy. As a new clinical option reaches the market, Medicare will reimburse—but only if the patient participates in a clinical study and these studies are paid for by either vendors or …
Medicare Changes Policy On New Med Procedures Read More »
This post is only available to members.